Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

James Suen to Aged

This is a "connection" page, showing publications James Suen has written about Aged.

 
Connection Strength
 
 
 
0.337
 
  1. Sherman AC, Simonton-Atchley S, Mikeal CW, Anderson KM, Arnaoutakis K, Hutchins LF, Makhoul I, Mahmoud F, Milojkovic N, Harrington SE, Suen JY. Cancer patient perspectives regarding preparedness for end-of-life care: A qualitative study. J Psychosoc Oncol. 2018 Jul-Aug; 36(4):454-469.
    View in: PubMed
    Score: 0.060
  2. Sims JR, Suen JY. First bite syndrome: case report of 3 patients treated with botulinum toxin and review of other treatment modalities. Head Neck. 2013 Sep; 35(9):E288-91.
    View in: PubMed
    Score: 0.040
  3. Payakachat N, Ounpraseuth S, Suen JY. Late complications and long-term quality of life for survivors (>5 years) with history of head and neck cancer. Head Neck. 2013 Jun; 35(6):819-25.
    View in: PubMed
    Score: 0.040
  4. Shafirstein G, Friedman A, Siegel E, Moreno M, B?umler W, Fan CY, Morehead K, Vural E, Stack BC, Suen JY. Using 5-aminolevulinic acid and pulsed dye laser for photodynamic treatment of oral leukoplakia. Arch Otolaryngol Head Neck Surg. 2011 Nov; 137(11):1117-23.
    View in: PubMed
    Score: 0.038
  5. Vural E, Fan CY, Spring P, Stack BC, Kokoska MS, Hanna EY, Suen JY. Evaluation of the inferior and superior laryngeal nerve stumps for perineural spread in laryngeal cancer. Otolaryngol Head Neck Surg. 2007 Dec; 137(6):889-92.
    View in: PubMed
    Score: 0.029
  6. Hanna E, Alexiou M, Morgan J, Badley J, Maddox AM, Penagaricano J, Fan CY, Breau R, Suen J. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations. Arch Otolaryngol Head Neck Surg. 2004 Jul; 130(7):861-7.
    View in: PubMed
    Score: 0.023
  7. Hanna E, Sherman A, Cash D, Adams D, Vural E, Fan CY, Suen JY. Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg. 2004 Jul; 130(7):875-9.
    View in: PubMed
    Score: 0.023
  8. Fife RS, Chase WF, Dore RK, Wiesenhutter CW, Lockhart PB, Tindall E, Suen JY. Cevimeline for the treatment of xerostomia in patients with Sj?gren syndrome: a randomized trial. Arch Intern Med. 2002 Jun 10; 162(11):1293-300.
    View in: PubMed
    Score: 0.020
  9. Kocdor P, Siegel ER, Suen JY, Richter G, Tulunay-Ugur OE. Comorbidities and factors associated with endoscopic surgical outcomes in adult laryngotracheal stenosis. Eur Arch Otorhinolaryngol. 2016 Feb; 273(2):419-24.
    View in: PubMed
    Score: 0.012
  10. Shalin SC, Cifarelli CP, Suen JY, Gao L. Loss of cytokeratin 20 and acquisition of thyroid transcription factor-1 expression in a merkel cell carcinoma metastasis to the brain. Am J Dermatopathol. 2014 Nov; 36(11):904-6.
    View in: PubMed
    Score: 0.012
  11. Wolf GT, Fee WE, Dolan RW, Moyer JS, Kaplan MJ, Spring PM, Suen J, Kenady DE, Newman JG, Carroll WR, Gillespie MB, Freeman SM, Baltzer L, Kirkley TD, Brandwein HJ, Hadden JW. Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer. Head Neck. 2011 Dec; 33(12):1666-74.
    View in: PubMed
    Score: 0.009
  12. Zuo C, Zhang H, Spencer HJ, Vural E, Suen JY, Schichman SA, Smoller BR, Kokoska MS, Fan CY. Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg. 2009 Oct; 141(4):484-90.
    View in: PubMed
    Score: 0.008
  13. Zuo C, Ai L, Ratliff P, Suen JY, Hanna E, Brent TP, Fan CY. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):967-75.
    View in: PubMed
    Score: 0.006
  14. Ai L, Vo QN, Zuo C, Li L, Ling W, Suen JY, Hanna E, Brown KD, Fan CY. Ataxia-telangiectasia-mutated (ATM) gene in head and neck squamous cell carcinoma: promoter hypermethylation with clinical correlation in 100 cases. Cancer Epidemiol Biomarkers Prev. 2004 Jan; 13(1):150-6.
    View in: PubMed
    Score: 0.006
  15. Ai L, Stephenson KK, Ling W, Zuo C, Mukunyadzi P, Suen JY, Hanna E, Fan CY. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases. Mod Pathol. 2003 Sep; 16(9):944-50.
    View in: PubMed
    Score: 0.005
  16. Mukunyadzi P, Liu K, Hanna EY, Suen JY, Fan CY. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma. Mod Pathol. 2003 Aug; 16(8):796-801.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.